The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.
The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.
Results are available within a fortnight.
Online:
www.healthlinx.com.au
Phone: 03 9208 4200
Phone: 03 9208 4200
Related Products
Bio-Rad Laboratories StarBright Dyes for spectral flow cytometry
The range provides users with more options when designing spectral flow cytometry panels,...
MaxWell Biosystems MaxOne+ HD-MEA Chip
The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...
Immundiagnostik ID-Vit MTP assays
Immundiagnostik's ID-Vit MTP assays range enables the quantification of all eight...
